Bunkerhill ECG-EF vs Autoplaque

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Bunkerhill ECG-EF

by Bunkerhill Health

Autoplaque

by APQ Health (formerly Cedars-Sinai Medical Center: AIM)

AI Verdict

Tool A (Bunkerhill ECG-EF) utilizes routine 12-lead ECGs to detect reduced left ventricular ejection fraction, aiding in the early identification of heart failure risk. In contrast, Tool B (Autoplaque) analyzes CT angiography images for quantitative assessment of coronary plaques and luminal stenoses to predict heart attack risk. While both are FDA-cleared AI tools in cardiology, they employ different diagnostic modalities and focus on distinct cardiac conditions, making them complementary rather than directly interchangeable.

Choose Bunkerhill ECG-EF if…

Choose Bunkerhill ECG-EF if your primary goal is rapid, non-invasive screening for early identification of patients at risk for heart failure using existing 12-lead ECG data. This tool is ideal for integrating into automated clinical workflows within EHRs to efficiently flag individuals with potentially reduced left ventricular ejection fraction (LVEF ≤ 40%) for further cardiac evaluation.

View Bunkerhill ECG-EF →

Choose Autoplaque if…

Choose Autoplaque if you require detailed, quantitative analysis of coronary atherosclerotic plaque and luminal stenoses from CT angiography images. This workstation-based software is best suited for advanced cardiac imaging centers needing precise measurements to refine heart attack risk prediction and guide targeted treatment strategies for patients with known or suspected coronary artery disease.

View Autoplaque →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Bunkerhill ECG-EF	Autoplaque
Pricing	Contact sales for pricing details.	Unknown
Deployment	Cloud-native platform (Carebricks) that integrates with existing health system infrastructure like EHRs.	Workstation-based post-processing application, runs on Windows or Mac OS.
FDA Status	Yes AI-estimated	1 AI-estimated
HIPAA	Yes AI-estimated	Unknown

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Bunkerhill ECG-EF	Autoplaque
Name	Bunkerhill ECG-EF	Autoplaque
Company	BunkerHill Health	Cedars-Sinai Medical Center: AIM
Description	FDA-cleared artificial intelligence algorithm that detects reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead electrocardiograms (ECGs), aiding in the early identification of patients at risk for heart failure.	FDA-cleared AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance.
Primary Data Input	Routine 12-lead electrocardiograms (ECGs)	CT angiography images
Key Functionality	Detects reduced Left Ventricular Ejection Fraction (LVEF u2264 40%)	Quantitative analysis of atherosclerotic plaque and measurement of luminal stenoses

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill ECG-EF and Autoplaque.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical purpose of each tool?

Bunkerhill ECG-EF is designed to detect reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead ECGs, aiding in the early identification of patients at risk for heart failure. Autoplaque provides quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, assisting in heart attack risk prediction and treatment guidance.

What type of patient data do these tools analyze?

Bunkerhill ECG-EF analyzes routine 12-lead electrocardiogram (ECG) data. Autoplaque performs its analysis on CT angiography images.

How do these tools integrate into existing clinical workflows?

Bunkerhill ECG-EF integrates seamlessly with Electronic Health Records (EHRs) and clinical archives or ECG Management Systems (EMS). Autoplaque is workstation-based software that runs on Windows or Mac computer platforms.

What are the key outputs or measurements provided by each tool?

Bunkerhill ECG-EF provides an AI algorithm to detect reduced LVEF (u2264 40%). Autoplaque offers AI-powered quantitative analysis of atherosclerotic plaque, detection and characterization of coronary artery plaque, and measurement of luminal stenoses.

Do these tools offer automated features that can be reviewed or edited by a clinician?

Bunkerhill ECG-EF supports automated clinical workflows and provides results that aid in clinical decision-making. Autoplaque features automated vessel, plaque, and lumen segmentation, which can be reviewed and edited by a clinician.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform